No profile data available.
NeurAxis, Inc. (NRXS) is a healthcare company in the targeted healthcare equipment industry, based in Carmel, United States, with about 24 full-time employees.
It reported revenue of $3.57 million for fiscal year 2025, up 32.9% from fiscal year 2024, and net income of -$8.62 million. Its market capitalization was $87.03 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States.
NeurAxis reported $3.57 million in revenue for fiscal year 2025, up 32.9% from $2.69 million in fiscal year 2024.
$87.03 million as of October 9, 2026.
Listed companies of a similar size in the same industry (targeted healthcare equipment) include Nyxoah SA (NYXH), Humacyte, Inc. (HUMA), electroCore, Inc. (ECOR), Outset Medical, Inc. (OM).